We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

749 hedge funds and large institutions have $48.9B invested in Allergan Inc in 2014 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 217 increasing their positions, 362 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $47B → $48.9B (+$1.87B)

3% less funds holding

Funds holding: 770749 (-21)

14% less funds holding in top 10

Funds holding in top 10: 7464 (-10)

16% less first-time investments, than exits

New positions opened: 68 | Existing positions closed: 81

40% less repeat investments, than reductions

Existing positions increased: 217 | Existing positions reduced: 362

47% less call options, than puts

Call options by funds: $851M | Put options by funds: $1.61B

Holders
749
Holders Change
-21
Holders Change %
-2.73%
% of All Funds
21.74%
Holding in Top 10
64
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-13.51%
% of All Funds
1.86%
New
68
Increased
217
Reduced
362
Closed
81
Calls
$851M
Puts
$1.61B
Net Calls
-$761M
Net Calls Change
-$531M
Name Holding Trade Value Shares
Change
Change in
Stake
PSCM
1
Pershing Square Capital Management
New York
$5.15B
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$3.25B +$382M +2,297,605 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.84B +$127M +764,192 +5%
State Street
4
State Street
Massachusetts
$2.19B -$94M -565,991 -4%
State Farm Mutual Automobile Insurance
5
State Farm Mutual Automobile Insurance
Illinois
$1.88B
BIT
6
BlackRock Institutional Trust
California
$1.4B -$160M -961,902 -11%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$1.25B +$474M +2,853,352 +68%
JSP
8
Jackson Square Partners
California
$1.12B -$70.9M -427,060 -6%
PC
9
Paulson & Co
New York
$958M -$37.3M -224,800 -4%
Jennison Associates
10
Jennison Associates
New York
$781M -$17.2M -103,271 -2%
SC
11
Sculptor Capital
New York
$693M +$218M +1,312,369 +51%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$684M -$3.4M -20,465 -0.5%
PCM
13
Pentwater Capital Management
Florida
$650M -$44.8M -269,462 -7%
Northern Trust
14
Northern Trust
Illinois
$648M -$22.3M -134,332 -4%
AllianceBernstein
15
AllianceBernstein
Tennessee
$641M -$2.55M -15,371 -0.4%
BFA
16
BlackRock Fund Advisors
California
$603M +$24M +144,625 +4%
O
17
OppenheimerFunds
New York
$544M -$101M -606,528 -17%
Parnassus Investments
18
Parnassus Investments
California
$535M +$43.3M +260,613 +9%
Edgewood Management
19
Edgewood Management
Connecticut
$481M +$2.92M +17,601 +0.7%
BG
20
BlackRock Group
United Kingdom
$475M +$26.1M +157,235 +6%
Polen Capital Management
21
Polen Capital Management
Florida
$436M -$12.3M -73,799 -3%
Franklin Resources
22
Franklin Resources
California
$410M -$13.9M -83,845 -4%
Viking Global Investors
23
Viking Global Investors
Connecticut
$406M +$245M +1,476,367 +184%
SCM
24
Steadfast Capital Management
New York
$396M +$52.7M +317,603 +17%
Norges Bank
25
Norges Bank
Norway
$388M -$361M -2,175,033 -50%

AGN Hedge Fund Activity: Q3 2014 in Review

749 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q3 2014, worth a combined $48.9B — up 4% from $47B a quarter earlier.

Sellers outnumbered buyers: 81 funds closed out of AGN and 68 opened new positions — a net loss of 13 holders — while 362 trimmed existing stakes and 217 added.

The largest buyer was Fidelity Investments, adding an estimated $474M. The largest seller was Norges Bank, cutting an estimated $361M.

  • 749 institutional investors held Allergan Inc (AGN) as of Q3 2014, down from 770 in Q2 2014.
  • Funds reported $48.9B of Allergan Inc stock for Q3 2014, up 4% quarter-over-quarter.
  • 68 funds opened new Allergan Inc positions in Q3 2014 and 81 closed out, a net change of -13 holders.
  • The largest Allergan Inc buyer in Q3 2014 was Fidelity Investments, an estimated $474M added.
  • The largest Allergan Inc seller in Q3 2014 was Norges Bank, an estimated $361M sold.

Based on aggregated 13F filings for Q3 2014.